Beximco Pharmaceuticals (LSE:BXP) FCF Margin %: -10.71% (As of Dec. 2024)


LSE:BXP Beximco Pharmaceuticals PLC LSE:BXP
97 GF Score
Price £0.43
View Full Analysis

What is Beximco Pharmaceuticals FCF Margin %?

Beximco Pharmaceuticals LSE:BXP 97 FCF Margin % is -10.71% as of Dec. 2024. GuruFocus rates LSE:BXP with a GF Score™ of 97/100.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Beximco Pharmaceuticals's Free Cash Flow for the three months ended in Dec. 2024 was £-7.9 Mil. Beximco Pharmaceuticals's Revenue for the three months ended in Dec. 2024 was £74.1 Mil. Therefore, Beximco Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2024 was -10.71%.

As of today, Beximco Pharmaceuticals's current FCF Yield % is 0.00%.

The historical rank and industry rank for Beximco Pharmaceuticals's FCF Margin % or its related term are showing as below:

LSE:BXP' s FCF Margin % Range Over the Past 10 Years
Min: -2.22   Med: 0   Max: 0
Current: -2.22

LSE:BXP's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.445 vs LSE:BXP: -2.22

Beximco Pharmaceuticals FCF Margin % Related Terms

Beximco Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Beximco Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beximco Pharmaceuticals FCF Margin % Chart

Beximco Pharmaceuticals Annual Data
Trend Dec15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.76 11.75 6.56 8.59 13.81

Beximco Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.06 -3.78 -5.79 11.60 -10.71

LSE:BXP vs ZTS, UTHR: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beximco Pharmaceuticals FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Beximco Pharmaceuticals's FCF Margin % falls into.


LSE:BXP
97GF Score
Beximco Pharmaceuticals PLC LSE:BXP
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beximco Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Beximco Pharmaceuticals's FCF Margin for the fiscal year that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2024 )/Revenue (A: Jun. 2024 )
=36.947/267.562
=13.81 %

Beximco Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-7.941/74.133
=-10.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -10.71% mean?
Beximco Pharmaceuticals (LSE:BXP) has a FCF Margin % of -10.71% as of Dec. 2024. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Beximco Pharmaceuticals and its competitors.
Is Beximco Pharmaceuticals' FCF Margin % too high?
Beximco Pharmaceuticals' current FCF Margin % is -10.71%. Overall, Beximco Pharmaceuticals has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Beximco Pharmaceuticals' FCF Margin % compare to ZTS and UTHR?
Beximco Pharmaceuticals' FCF Margin % of -10.71% can be compared against companies in the Drug Manufacturers industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Beximco Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beximco Pharmaceuticals's current FCF Margin % is -10.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beximco Pharmaceuticals stock overvalued right now?
Beximco Pharmaceuticals (LSE:BXP) has a current FCF Margin % of -10.71%. The current FCF Margin % is -10.71%. Beximco Pharmaceuticals' overall GF Score™ is 97/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Beximco Pharmaceuticals (LSE:BXP), the current FCF Margin % is -10.71% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beximco Pharmaceuticals Business Description

Address 19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.
97GF Score

Get the complete analysis for LSE:BXP

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.43
Price